Further semiquantitative assessment of the intensity of P-gp immunohistochemical staining in tumor sections revealed that treatment with Sol-DMAP, either as a single agent or in combination with DOX, resulted in an approximately 2-fold decrease in P-gp expression, while DOX alone did not affect P-gp level (Figure 3D). The gene discussed is PGP; the disease is neoplasm.